Baselga Cancer Research Scholar

Baselga Cancer Research Scholar   “It is critical that we build and maintain our rich tradition of clinical expertise in support of developing life-changing medicines for patients.” –Jose Baselga   The Baselga Cancer Research Scholars Program, initiated in 2020 , is a 2-year immersive education and research program for early-career Oncologists who are inspired by science and by how clinical development has the potential to transform patient care .  As part of a competitively selected cohort of Scholars, you will join an acce lerated developmen t tra ck within Oncology R&D . W ith individualized mentorship , there is opportunity to learn from a diverse group of experts across the drug development continuum, playing a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients’ lives. Selected Scholars will join the current cohort of Baselga Cancer Research Scholars, build ing a vib rant community of drug developers. We are currently recruiting for the 202 7 class with an aim to start the position in summer-autumn 202 7 .   About AstraZeneca Oncology Research & Development   Our Oncology strategy is built with one goal in mind – pushing the boundaries of science to deliver life-changing medicines to patients. We have a passion for discovery and a broad pipeline of next-generation medicines, and together with a focus on execution excellence, we aim to expand treatment options and improve outcomes for patients with solid and haematological cancers. We’re pioneering innovative research across six scientific platforms: Tumor drivers and resistance; Immuno-oncology, DNA damage response, Antibody drug conjugates, Epigenetics and Cell therapies.   Our ambition is to eliminate cancer as a cause of death. It’s our big vision that unites and inspires us. With multiple indications and high-quality molecules at all stages of our innovative pipeline, we keep pushing forward. Focusing on cutting-edge science with the latest technology to achieve breakthroughs .   AZ is a place built on courage, curiosity and collaboration – we make bold decisions driven by patient outcomes.   What you’ll do   The 202 7 AZ Baselga Cancer Research Scholars cohort will join AstraZeneca at a time of tremendous growth and acceleration in the oncology biologics portfolio. Working in a fast-paced and dynamic work environment you will experience increasing levels of responsibility, following a structured learning plan in the following domains:   1) Clinical Study Assignment: You will join a clinical study team and build experience as a medical leader in clinical development which could be in Early Clinical Development, Late Clinical Development, or one year in each. You will participate in weekly clinical and scientific meetings related to your clinical study, complete AstraZeneca training programs and participate in internal and external scientific meetings. You will work in a cross functional environment, contributing to and supporting Department/Clinical initiatives to improve the quality and content of all clinical programs as well as the cross functional/organization processes designed to effectively deliver our R&D portfolio.   Specific duties and major responsibilities for the longitudinal medical project may include any of the following:     Serving as m edical dire ctor with primary responsibility for patient safety and conduct of assigned trials as well as overall data interpretation and safety surveillance   Establishing and approving scientific methods for design and implementation of applicable clinical protocols, data collection systems, and final reports   Assisting in design of clinical development plans and overall strategy for compounds, therapeutic classes of compounds or indications in light of developments in the area of clinical and pharmaceutical oncology   Collaborating with pre-clinical and translational sciences, and senior management in assessing requirements for emerging products   Participating in the selection and management activities of CROs   Supervising project team members in planning, conducting and evaluating clinical trials   Planning and managing investigator meetings, advisory boards and other scientific committees   2) Rotational program: During the course of your program, you will be involved in 3-6 month long rotations across various groups to gain a better understanding of the cross-functional departments. This could include: • Patient safety   • Clinical operations   • Regulatory affairs   • Biostatistics   • Medical affairs   • Translational medicine or precision medicine   3) Longitudinal Research Project: You will have opportunity to lea d an in n ovative research project of your choosing for the duration of the 2-year program, which may be an area of special interest to you and AstraZeneca, or alternatively focus on one or more of the rotational functions. Y ou will be able t o harne ss rich interna l d atasets and ex pertise , aimi ng to deliver a res earch project at the end of the Program which will be p resented to key internal stakeholders, at a key scientific meeting and published in a peer-reviewed journal.   Essential for the role:   MD or equivalent required; ideally board certified (or eligible) preferred in Oncology or Haematology/Oncology    0-5 years of experience in molecular oncology and/or translational science Highly Desirable for the role:   Experience in molecular oncology and/or translational science   Medical specialty and sub-specialty training and Board Certification   Excellent oral and written skills, strong interpersonal and listening skills   Results driven to achieve creative and sound outcomes   Proven leadership skills and demonstrated ability to interact collaboratively in a cross-functional environment.   Ability to make sound and timely decisions; agile in learning and action oriented   High level of emotional intelligence; a